BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simkens GA, Rovers KP, van Oudheusden TR, Nienhuijs SW, Rutten HJ, de Hingh IH. Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases. Medicine (Baltimore) 2018;97:e0042. [PMID: 29517660 DOI: 10.1097/MD.0000000000010042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Bakkers C, Simkens GAAM, De Hingh IHJT. Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research. J Gastrointest Oncol 2021;12:S206-13. [PMID: 33968438 DOI: 10.21037/jgo-20-133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mielko J, Rawicz-Pruszyński K, Sędłak K, Gęca K, Kwietniewska M, Polkowski WP. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes. Cancers (Basel) 2020;12:E2387. [PMID: 32842535 DOI: 10.3390/cancers12092387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Kooijman BJL, Hentzen JEKR, van der Hilst CS, Been LB, van Ginkel RJ, Hemmer PHJ, Klaase JM, Kruijff S. Impact of extent of disease on 1-year healthcare costs in patients who undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: retrospective observational cohort study. BJS Open 2020;4:954-62. [PMID: 32652904 DOI: 10.1002/bjs5.50320] [Reference Citation Analysis]